You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
恆指受制21,300升幅曾收窄至53點 美團回升逾3% 藥明生物續挫6.5%
美聯儲如期加息半釐爲22年來最多,但下月纔開始縮表每月金額僅475億美元,3個月後上限提高至每月950億美元,主席鮑威爾會後透露並無積極考慮單次加息75點子,紓緩市場對局方未來大幅加息遏抑通脹導致經濟陷入衰退憂慮,美股三大指數昨晚在各板塊全面報升帶動高收急漲2.8%-3.2%。然而,美股期貨全面回吐不足0.2%。亞太股市今早全面造好,但升幅均不足1%。 標普香港4月PMI四個月來首呈擴張,由前值42,急升至51.7,反映私企經濟回覆景氣,且增速爲五個月來最快。恆指繼昨天在新經濟股及內需股捱沽拖累回吐1.1%後,今早高開293點或1.4%報21,163,升幅曾擴至415點或2%高見21,284遇阻,升幅曾收窄至僅53點低見20,923,現報21,001,僅回升132點或0.6%,20天線(21,053)得而復失,成交額549億元。 藍籌股普遍造好,但高位欠承接;遭股東再減持昨天下挫的美團(03690.HK)高見173.4元,現報169.7元,回升3.2%;京東(09618.HK)及阿裏(09988.HK)高見249.4元及101.1元,現報243元及98.3元,僅回升1.4%及1.8%;騰訊(00700.HK)由高位378元,掉頭曾倒跌低見368元,現報369.4元,僅彈0.3%。 金融股以港交所(00388.HK)較爲堅挺,最高見346元,現報341.8元,回升1.4%;匯控(00005.HK)三連升,最高見51.8元及(暫受制百天線51.9元),現報51.15元,僅續升0.8%。然而,四大藍籌內銀逆市反覆偏軟。 阿裏健康(00241.HK)及石藥(01093.HK)升逾2.5%-3.5%,分別高見4.26元及8.4元;但藥明生物(02269.HK)逆市反覆兩連跌,最高見58.95元遇阻,掉頭低見52.3元,現報53.5元,續跌6.5%。
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account